Detail Data
Volume (24h): 3,336,970 shares
P/E Ratio: /
Forward P/E: 26.11
EPS: -0.5 USD
Forward EPS: 0.36 USD
Number of Shares: 120,081,000 shares
Market Capitalization: 1,128,761,344.00 USD

Dividend

Dividend Value
Dividend Amount According to our data, the company Dynavax Technologies does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a buy recommendation for Dynavax Technologies stock. The current number of analysts covering this company is 4. The highest target price is 31 USD, while the lowest target price is 11.1 USD. The median target valuation set by analysts is 25.5 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Dynavax Technologies.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Dynavax Technologies stock is: buy
Number of Analysts: 4
Highest Target Price: 31 USD
Lowest Target Price: 11.1 USD
Median Target Price: 25.5 USD

Fundamental Indicators

Indicator Data
Total Revenue: 294,620,000.00 USD
Net Income: -60,069,000.00 USD
Price-to-Book (P/B): 2.19
PEG Ratio: /
Exchange: NasdaqGS
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Number of Employees: 405
Country: United States

Where to Buy Dynavax Technologies Stock?

You can purchase Dynavax Technologies stock on the NasdaqGS under the ticker symbol: DVAX. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Dynavax Technologies Stock

Indicator Value
Company Revenue: 294,620,000.00 USD
EBITDA: 3,535,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: -0.5 USD
Book Value Per Share: 4.29 USD
Total Cash: 661,336,000.00 USD
Total Cash per Share: 5.51 USD
Total Debt: 290,108,000.00 USD
Debt to Equity Ratio: 0.55
Quick Ratio 10.52
Current Ratio 11.93
Free Cash Flow 33,543,500.00 USD
Operating Cash Flow 63,552,000.00 USD
Gross Margins 60.29 %
EBITDA Margins 1.20 %
Operating Margins -31.40 %
Profit Margins -20.39 %
Return on Assets -0.1 %
Return on Equity -10.5 %
Earnings Growth (1 year) -
Revenue Growth (1 year) 34.2 %
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 1,128,761,344.00 USD
Enterprise Value 757,530,112.00 USD
EV/Revenue 2.571
EV/EBITDA 214.294
Float Shares 95,203,542 shares
Shares Outstanding 120,081,000 shares
Held Percent Insiders 0.01 %
Held Percent Institutions 108.39 %
Shares Short 19,614,189
Shares Short Prior Month 18,397,661
Date Short Interest 2025-04-30
Short Percentage of Total Shares 16.02 %
Short Ratio 6.95
Beta 1.26
Short Percentage of Float 23.63 %
Implied Shares Outstanding 120,081,000

Frequently Asked Questions (FAQ)

According to our data, the company Dynavax Technologies does not pay dividends yet, even in 2025.

Dynavax Technologies shares are traded on the NasdaqGS stock exchange under the ticker: DVAX. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Dynavax Technologies shares is from a total of 4 analysts. The average target price prediction is 25.5 USD per share.

The total number of Dynavax Technologies shares on the exchange is 120,081,000.00 shares, which at the current market capitalization gives the company a total valuation of 1,128,761,344.00 USD.